JP5053519B2 - Plant trypsin inhibitor - Google Patents
Plant trypsin inhibitor Download PDFInfo
- Publication number
- JP5053519B2 JP5053519B2 JP2005099907A JP2005099907A JP5053519B2 JP 5053519 B2 JP5053519 B2 JP 5053519B2 JP 2005099907 A JP2005099907 A JP 2005099907A JP 2005099907 A JP2005099907 A JP 2005099907A JP 5053519 B2 JP5053519 B2 JP 5053519B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- genus
- plant
- plants
- buckwheat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002753 trypsin inhibitor Substances 0.000 title description 9
- 229940122618 Trypsin inhibitor Drugs 0.000 title description 4
- 101710162629 Trypsin inhibitor Proteins 0.000 title description 4
- 239000000284 extract Substances 0.000 claims description 59
- 241000196324 Embryophyta Species 0.000 claims description 19
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 11
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 9
- 244000046146 Pueraria lobata Species 0.000 claims description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 8
- 240000006108 Allium ampeloprasum Species 0.000 claims description 7
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 7
- 240000001980 Cucurbita pepo Species 0.000 claims description 7
- 239000003001 serine protease inhibitor Substances 0.000 claims description 7
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 6
- 229940122055 Serine protease inhibitor Drugs 0.000 claims description 6
- 101710102218 Serine protease inhibitor Proteins 0.000 claims description 6
- 244000046101 Sophora japonica Species 0.000 claims description 4
- 235000001484 Trigonella foenum graecum Nutrition 0.000 claims description 4
- 244000250129 Trigonella foenum graecum Species 0.000 claims description 4
- 235000010724 Wisteria floribunda Nutrition 0.000 claims description 4
- 240000004244 Cucurbita moschata Species 0.000 claims description 3
- 244000302512 Momordica charantia Species 0.000 claims description 3
- 235000009811 Momordica charantia Nutrition 0.000 claims description 3
- 241000729176 Fagopyrum dibotrys Species 0.000 claims description 2
- 244000086995 Hypolytrum humile Species 0.000 claims description 2
- 241001633680 Polygonatum odoratum Species 0.000 claims description 2
- 241000246044 Sophora flavescens Species 0.000 claims description 2
- 235000010586 Sophora japonica Nutrition 0.000 claims description 2
- 241001099143 Wisteria brachybotrys Species 0.000 claims description 2
- 239000001917 trigonella foenum graecum l. absolute Substances 0.000 claims description 2
- 235000001019 trigonella foenum-graecum Nutrition 0.000 claims description 2
- 241000234282 Allium Species 0.000 claims 1
- 244000003377 Allium tuberosum Species 0.000 claims 1
- 235000005338 Allium tuberosum Nutrition 0.000 claims 1
- 241000220485 Fabaceae Species 0.000 claims 1
- 244000018795 Prunus mume Species 0.000 claims 1
- 235000011158 Prunus mume Nutrition 0.000 claims 1
- 240000003970 Schefflera tomentosa Species 0.000 claims 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 239000002537 cosmetic Substances 0.000 description 20
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 239000000419 plant extract Substances 0.000 description 16
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 14
- 230000008099 melanin synthesis Effects 0.000 description 14
- 230000002087 whitening effect Effects 0.000 description 14
- 239000003112 inhibitor Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 244000068988 Glycine max Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000002510 keratinocyte Anatomy 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 235000010469 Glycine max Nutrition 0.000 description 8
- 108090000631 Trypsin Proteins 0.000 description 8
- 102000004142 Trypsin Human genes 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000012588 trypsin Substances 0.000 description 8
- 229940058015 1,3-butylene glycol Drugs 0.000 description 7
- 244000302544 Luffa aegyptiaca Species 0.000 description 7
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 7
- 102000012479 Serine Proteases Human genes 0.000 description 7
- 108010022999 Serine Proteases Proteins 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- -1 pH adjusters Substances 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 210000002780 melanosome Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 235000000832 Ayote Nutrition 0.000 description 4
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 206010070835 Skin sensitisation Diseases 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000015136 pumpkin Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 231100000370 skin sensitisation Toxicity 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 3
- 108010052968 leupeptin Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- 102000002045 Endothelin Human genes 0.000 description 2
- 108050009340 Endothelin Proteins 0.000 description 2
- 240000000731 Fagus sylvatica Species 0.000 description 2
- 235000010099 Fagus sylvatica Nutrition 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 2
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 2
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 241000596467 Ononis Species 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940087603 grape seed extract Drugs 0.000 description 2
- 235000002532 grape seed extract Nutrition 0.000 description 2
- 235000020717 hawthorn extract Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229960001755 resorcinol Drugs 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940119463 sunflower seed extract Drugs 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000252185 Cobitidae Species 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241001126925 Lobata Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 241000334657 Scorzonera tomentosa Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001300423 Strophostyles Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 244000196981 Unident Fabaceae sp Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 238000003811 acetone extraction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000020765 fenugreek extract Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000453 juniperus communis l. leaf oil Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、セリンプロテアーゼ活性阻害剤に関する。特にトリプシン(Trypsin)に関わるセリンプロテアーゼの活性に対して、優れた拮抗作用を有するセリンプロテアーゼ活性阻害剤に関する。 The present invention relates to a serine protease activity inhibitor. In particular, the present invention relates to a serine protease activity inhibitor having an excellent antagonistic action against the activity of serine protease related to trypsin.
セリンプロテアーゼによりケラチノサイトの細胞膜上のプロテアーゼアクチベートレセプター-2(PAR-2)が活性化されることにより、ケラチノサイトへのメラノソームの取り込みが活性化される。本発明のセリンプロテアーゼ活性阻害剤は、ケラチノサイト細胞膜上のPAR-2の活性化を阻害することにより、ケラチノサイトへのメラノソームの取り込みを抑制し、角質層へのメラニンの拡散が防止される。このメラニンの拡散防止により、皮膚色に黒ずみが無くなる。さらに、直接メラノサイトでのメラニン産生を阻害する素材であるアスコルビン酸誘導体とを併用して、メラニン自体の産生量を減少させることにより強い美白効果を有する美白用化粧料が提供される。そして、セリンプロテアーゼは、活性部位にセリン残基のあるプロテアーゼであり、代表的なものにトリプシン、キモトリプシン、トロンビン、プラスミン、エラスターゼなどがある。 By activating protease activator receptor-2 (PAR-2) on the cell membrane of keratinocytes by serine protease, incorporation of melanosomes into keratinocytes is activated. The serine protease activity inhibitor of the present invention inhibits the activation of PAR-2 on the keratinocyte cell membrane, thereby suppressing the incorporation of melanosomes into keratinocytes and preventing the diffusion of melanin into the stratum corneum. By preventing the diffusion of melanin, the skin color is not darkened. Furthermore, a cosmetic for whitening having a strong whitening effect is provided by reducing the production amount of melanin itself in combination with an ascorbic acid derivative that is a material that directly inhibits melanin production in melanocytes. Serine protease is a protease having a serine residue in the active site, and representative ones include trypsin, chymotrypsin, thrombin, plasmin, and elastase.
従来より、紫外線による皮膚の黒化や、シミ,ソバカスといった皮膚の色素沈着を防止又は改善するため、メラニン産生を阻害したり、生成したメラニン色素を還元する作用を有する成分がスクリーニングされ美白化粧料に配合されてきた。例えば、アスコルビン酸、システイン、及びこれらの誘導体、胎盤抽出物、植物,藻類よりの抽出物などが利用されている。 Conventionally, whitening cosmetics have been screened for ingredients that have the action of inhibiting melanin production or reducing the produced melanin pigment in order to prevent or improve skin darkening due to ultraviolet rays and skin pigmentation such as spots and freckles. Has been formulated. For example, ascorbic acid, cysteine, and derivatives thereof, placental extracts, extracts from plants and algae are used.
しかしながら、アスコルビン酸、システイン、およびこれらの誘導体は、酸化還元反応を受けやすく不安定であった。また、胎盤抽出物や植物,藻類よりの抽出物は有効量を配合すると美白化粧料に好ましくない臭いや色を付与したり、また、美白効果も充分ではなく、多くの問題点があった。 However, ascorbic acid, cysteine, and derivatives thereof are susceptible to redox reactions and are unstable. In addition, when an effective amount of a placenta extract, an extract from a plant, or an algae is added, an unpleasant odor or color is imparted to the whitening cosmetics, and the whitening effect is not sufficient, resulting in many problems.
また最近では、特表2001-502360に記載されているような、ケラチノサイトによるメラノソームの貪食を抑制することにより、皮膚の色素沈着を抑制しようとする試みがなされている。メラニンはメラノサイトのなかのメラノソーム中で産生され、これがケラチノサイトに貪食される。これによりメラニンが表皮全体に分布されることになる。これをトリプシンインヒビターを用いることにより、ケラチノサイトによるメラノソームの貪食を抑制し、メラニンの拡散を防止しようとするものである。 Recently, attempts have been made to suppress skin pigmentation by suppressing melanosome phagocytosis by keratinocytes as described in JP-T-2001-502360. Melanin is produced in melanosomes among melanocytes, which are phagocytosed by keratinocytes. This causes melanin to be distributed throughout the epidermis. By using a trypsin inhibitor, the melanosome phagocytosis by keratinocytes is suppressed and the diffusion of melanin is prevented.
しかしながら、この方法によってもトリプシンインヒビターが直接メラニン産生に作用するもので無いため、美白化粧料として充分な効果を発揮するものではなかった。
本発明の課題は、皮膚刺激性や皮膚感作性といった安全性上の問題がなく、強い皮膚のメラニン産生阻害作用を有し、かつ産生されたメラニンのケラチノサイトへの分散を阻害する高い美白効果を有する化粧料の提供である。 The problem of the present invention is that there is no safety problem such as skin irritation and skin sensitization, a strong skin melanin production inhibitory action, and a high whitening effect that inhibits the dispersion of produced melanin to keratinocytes The provision of cosmetics having
本発明においては、上記のような問題点を解決し、強い皮膚のメラニン産生阻害作用を有し、かつ産生されたメラニンのケラチノサイトへの分散を阻害することにより、皮膚刺激性や皮膚感作性といった安全性上の問題のない効果の高い美白化粧料を開発するに至った。 In the present invention, by solving the above problems, having a strong skin melanin production inhibitory effect, and inhibiting the dispersion of the produced melanin to keratinocytes, skin irritation and skin sensitization This led to the development of whitening cosmetics that are highly effective and have no safety problems.
即ち、本発明はユリ科アマドコロ属、ネギ属、マメ科クララ属、クズ属、ダイズ属、フジ属、フォエヌム・グラエクム属、ウリ科カボチャ属、ニガウリ属、ヘチマ属、タデ科ソバ属、セリ科ウイキョウ属、アブラナ科アルバ属植物の中から選ばれる1種または2種以上の化合物を含有するセリンプロテアーゼ阻害剤とメラニン産生抑制剤を含有する美白用化粧料を提供するものである。 That is, the present invention is a lily family Amadokora, leek genus, leguminous clara genus, kudzu genus, soybean genus, fuji genus, foenum glaecum genus, cucurbitaceae pumpkin genus, nigauri genus, loofah genus, aceae genus buckwheat, sericidae The present invention provides a whitening cosmetic composition containing a serine protease inhibitor and a melanin production inhibitor containing one or two or more compounds selected from the genus Falcon and Brassicaceae Alba.
本発明の化粧料は、皮膚刺激性や皮膚感作性といった安全性上の問題がなく、メラニン産生抑制物質とセリンプロテアーゼ阻害剤を配合することにより、高い美白効果を有するものである。 The cosmetic of the present invention does not have safety problems such as skin irritation and skin sensitization, and has a high whitening effect by blending a melanin production inhibitor and a serine protease inhibitor.
以下、本発明について詳述する。本発明に用いるセリンプロテアーゼ阻害作用を示すユリ科アマドコロ属植物としてはアマドコロ(Polygonatum odoratum(Mill.)Druce var.
pluriflorum(Miq.)Ohwi)、ヒメイズイ(P. humile Fisch.)、ナルコユリ(P.
falcatum A. Gray)が、ネギ属植物としてはニラ(Allium
tuberosum ROTLER)が、マメ科クララ属植物としてはクララ(Sophora flavescens Aiton)、エンジュ(S. japonica L.)イソフジ(S.
tomentosa L.が)、クズ属植物としてはクズ(Pueraria
lobata (Willd.)ohwi)が、ダイズ属植物としてはダイズ(Glycine max Merr.)、ツルマメ(G.soja Siebold et Zucc.)が、フジ属植物としてはノダフジ(Wistaria Floribunda(Willd.)DC.)、ヤマフジ(W.brachybotrys Siebold et Zucc.)が、フォエヌム・グラエクム属としてはコロハ(Trigonella foenum−graecum L.)が、ウリ科カボチャ属植物としてはカボチャ(Cucurbita moschata(Duchesne)Poir. var. meloniformis(Carriere)Makino)、セイヨウカボチャ(C. pepo L.)が、ニガウリ属植物としてはツルレイシ(Momordica charantia L.)(別名ニガウリ)が、ヘチマ属植物としてはヘチマ(Luffa aegyptiaca Mill.)が、タデ科ソバ属植物としてはソバ(Fagopyrum esculentum Moench)、(F.dibotrys(D.Don)H.Hara)が、セリ科ウイキョウ属植物としてはウイキョウ(Foeniculum vulgare Mill.)、アブラナ科アルバ属植物としてはシロガラシ(Sinapis alba L.)が利用できる。
Hereinafter, the present invention will be described in detail. Examples of the plant belonging to the genus Amidokolo, which exhibits serine protease inhibitory action for use in the present invention, are Amadochoro (Polygonatum odoratum (Mill.) Druce var.
pluriflorum (Miq.) Ohwi), P. humile Fisch., Naruko Yuri (P.
falcatum A. Gray) is a leek plant.
tuberosum R OTLER ), but the leguminous Clara genus is Clara (Sophora flavescens Aiton), Enju (S. japonica L.) Isofuji (S.
tomentosa L.), as a genus of genus Kudzu (Pueraria)
lobata (Willd.) ohwi), soybeans (Glycine max Merr.), peas (G.soja Siebold et Zucc.) as genus plants, Nodafuji (Wistaria Floribunda (Willd.) DC.) , Yamafuji (W.brachybotrys Siebold et Zucc.), Foenum Graekum genus Koroha (Trigonella foenum-graecum L.), Cucurbita moschata (Duchesne) Poir. Var. Meloniformis (Cucurbita moschata (Duchesne) Poir. Carriere) Makino), pumpkin (C. pepo L.), but as a plant of the genus Nigauri, Momordica charantia L. (aka Nigauri), and as a plant of the genus Locha (Luffa aegyptiaca Mill.) Buckwheat (Fagopyrum esculentum Moench) and (F.dibotrys (D.Don) H.Hara) are the common buckwheat plants, Feniculum vulgare Mill. Brush (Sinapis alba L.) is available.
また、上記植物類は種々の適当な有機溶媒を用いて、低温下及び/又は加温下で抽出されたエキスとして使用できる。 Moreover, the said plant can be used as an extract extracted under various low temperature and / or heating using various suitable organic solvents.
抽出溶媒としては、特に限定はされないが、例えば、水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1,3-ブチレングリコール等の液状多価アルコール;アセトン、メチルエチルケトン等のケトン;酢酸エチルなどのアルキルエステル;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテル等のエーテル類;ジクロルメタン、クロロホルム等のハロゲン化アルカン等の1種または2種以上を用いることが出来る。 とりわけ、水、エチルアルコール、1,3-ブチレングリコールの1種または2種以上の混合溶媒が特に好適である。 The extraction solvent is not particularly limited. For example, water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol; acetone, methyl ethyl ketone, and the like. One type or two or more types of ketones; alkyl esters such as ethyl acetate; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; halogenated alkanes such as dichloromethane and chloroform can be used. In particular, water, ethyl alcohol, or a mixed solvent of one or more of 1,3-butylene glycol is particularly suitable.
本発明に用いるメラニン産生抑制剤はエラグ酸及びその誘導体並びにそれらの塩、エンドセリン拮抗薬、アスコルビン酸及びその誘導体並びにそれらの塩、グルタチオン及びその誘導体並びにそれらの塩、システイン及びその誘導体並びにそれらの塩、レゾルシン及びその誘導体並びにそれらの塩、ハイドロキノン及びその誘導体並びにそれらの塩は市販の試薬類を利用することが出来る。また、これらの化合物を多く含有する植物から各種の溶媒、例えば、水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール;アセトン、メチルエチルケトン等のケトン;酢酸エチルなどのアルキルエステル;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテル等のエーテル類;ジクロルメタン、クロロホルム等のハロゲン化アルカン等の1種または2種以上を用いて抽出し、精製して使用することが出来る。さらには、化学的な合成によっても上記化合物を作成することが可能である。 Melanin production inhibitors used in the present invention are ellagic acid and its derivatives and their salts, endothelin antagonists, ascorbic acid and its derivatives and their salts, glutathione and their derivatives and their salts, cysteine and its derivatives and their salts Commercially available reagents can be used for resorcin and its derivatives and their salts, hydroquinone and its derivatives and their salts. Various solvents from plants containing a large amount of these compounds, such as water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol; acetone Extraction using 1 type or 2 types or more of alkyl esters such as ethyl acetate; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; halogenated alkanes such as dichloromethane and chloroform; It can be used after purification. Furthermore, the above compound can be prepared by chemical synthesis.
また、グラブリジン、グラブレン、リクイリチン、イソリクイリチン及びこれらを含有するカンゾウ抽出物、胎盤抽出物、カロチノイド類及びこれらを含有する動植物抽出物、イレイセン抽出物、ひまわり種子抽出物、イブキトラノオ抽出物、エイジツ抽出物、オウゴン抽出物、オノニス抽出物、海藻抽出物、ゴカヒ抽出物、リノール酸を含有する植物抽出物、リノレン酸を含有する植物抽出物、サイシン抽出物、サンザシ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、ソウハクヒ抽出物、茶抽出物、トウキ抽出物、ビャクレン抽出物、ブナノキ抽出物、ブドウ種子抽出物、ホップ抽出物、マイカイカ抽出物、ユキノシタ抽出物、ヨクイニン抽出物の調製は特に限定されないが、例えば種々の適当な有機溶媒を用いて低温下から加温下で抽出される。抽出溶媒としては、例えば、水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール;アセトン、メチルエチルケトン等のケトン;酢酸エチルなどのアルキルエステル;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテル等のエーテル類;ジクロルメタン、クロロホルム等のハロゲン化アルカン等の1種または2種以上を用いることが出来る。とりわけ、水、エチルアルコール、1,3−ブチレングリコールの1種または2種以上の混合溶媒が特に好適である。 Also, grabrizine, glabrene, liquiritin, isoliquiritin and licorice extract, placenta extract, carotenoids and animal and plant extracts containing these, irasen extract, sunflower seed extract, ibukitoranoo extract, age extract , Ogon extract, Ononis extract, Seaweed extract, Gokahi extract, Plant extract containing linoleic acid, Plant extract containing linolenic acid, Saisin extract, Hawthorn extract, Shirayuri extract, Peonies extract , Sempukuka extract, Sakuhakuhi extract, tea extract, Toki extract, sandalwood extract, beech extract, grape seed extract, hop extract, mica squid extract, saxifrage extract, Yokuinin extract are particularly limited Not at low temperature, for example using various suitable organic solvents It is extracted under heating from. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol; ketones such as acetone and methyl ethyl ketone; and ethyl acetate. One or more of alkyl esters; hydrocarbons such as benzene and hexane; ethers such as diethyl ether; and halogenated alkanes such as dichloromethane and chloroform can be used. In particular, one, two or more mixed solvents of water, ethyl alcohol, and 1,3-butylene glycol are particularly suitable.
本発明に用いるセリンプロテアーゼ阻害作用を示すユリ科アマドコロ属植物のアマドコロ、ヒメイズイ、ナルコユリ、ネギ属植物のニラ、マメ科クララ属植物のクララ、エンジュ、イソフジ、クズ属植物のクズ、ダイズ属のダイズ、ツルマメ、フジ属のノダフジ、ヤマフジ、フォエヌム・グラエクム属のコロハ、ウリ科カボチャ属のカボチャ、セイヨウカボチャ、ニガウリ属のツルレイシ(別名ニガウリ)、ヘチマ属のヘチマ、タデ科ソバ属のソバ、セリ科ウイキョウ属のウイキョウ、アブラナ科アルバ属のシロガラシの植物抽出エキスの配合量は、0.0001〜10.0重量%が好ましく、特に0.01〜1.0重量%の範囲が最適である。 Lentiaceae Amadokolo, Amadokolo, Nymphaea lily, Leek genus leek, Lariaceae Clara genus Clara, Enju, Isofuji, Kudzu genus kudzu, Soybean genus soybean , Wild bean, nodafuji of the genus Fuji, Yamafuji, Koroha of the genus Forenum graekum, pumpkin of the cucurbitaceae pumpkin, pumpkin of the sun 0.0001-10.0 wt% is preferable, and the range of 0.01-1.0 wt% is most suitable for the blending amount of the plant extract of Fennel spp.
メラニン産生抑制剤として用いるエラグ酸及びその誘導体並びにそれらの塩、エンドセリン拮抗薬、アスコルビン酸及びその誘導体並びにそれらの塩、グルタチオン及びその誘導体並びにそれらの塩、システイン及びその誘導体並びにそれらの塩、レゾルシン及びその誘導体並びにそれらの塩、ハイドロキノン及びその誘導体並びにそれらの塩、グラブリジン、グラブレン、リクイリチン、イソリクイリチン及びこれらを含有するカンゾウ抽出物、胎盤抽出物、カロチノイド類及びこれらを含有する動植物抽出物、イレイセン抽出物、ひまわり種子抽出物、イブキトラノオ抽出物、エイジツ抽出物、オウゴン抽出物、オノニス抽出物、海藻抽出物、ゴカヒ抽出物、リノール酸を含有する植物抽出物、リノレン酸を含有する植物抽出物、サイシン抽出物、サンザシ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、ソウハクヒ抽出物、茶抽出物、トウキ抽出物、ビャクレン抽出物、ブナノキ抽出物、ブドウ種子抽出物、ホップ抽出物、マイカイカ抽出物、ユキノシタ抽出物、ヨクイニン抽出物については、それぞれの素材を乾燥した後、細かく粉砕したものを重量比で1〜1000倍量、特に10〜100倍量の溶媒を用い、常温抽出の場合には、0℃以上、特に20℃〜40℃で1時間以上、特に3〜7日間行うのが好ましい。また、60〜100℃で1時間、加熱抽出しても良い。 Ellagic acid and its derivatives and their salts, endothelin antagonists, ascorbic acid and its derivatives and their salts, glutathione and their derivatives and their salts, cysteine and its derivatives and their salts, resorcin and their use as melanin production inhibitors Derivatives thereof and salts thereof, hydroquinone and derivatives thereof, and salts thereof, glabrizine, glabrene, liquiritin, isoliquiritin and licorice extract containing them, placenta extract, carotenoids and animal and plant extracts containing these, irasen extract , Sunflower seed extract, Ibukitorano extract, Ages extract, Ogon extract, Ononis extract, Seaweed extract, Gokahi extract, Plant extract containing linoleic acid, Plant extract containing linolenic acid, Saishi Extract, hawthorn extract, white lily extract, peony extract, sempukuka extract, Sakuhakuhi extract, tea extract, tea extract, juniper extract, beech extract, grape seed extract, hop extract, squid extract In the case of extraction at room temperature, using a 1 to 1000-fold amount, especially 10 to 100-fold amount of a solvent by weight of a finely pulverized product after drying each material, Is preferably carried out at 0 ° C. or higher, particularly 20 ° C. to 40 ° C. for 1 hour or longer, particularly 3 to 7 days. Moreover, you may heat-extract at 60-100 degreeC for 1 hour.
以上のような条件で得られる上記各抽出物は、抽出された溶液のまま用いても良いが、さらに必要により、濾過等の処理をして濃縮、粉末化したものを適宜使い分けて用いることが出来る。 Each of the above-mentioned extracts obtained under the above conditions may be used as an extracted solution. However, if necessary, it is necessary to appropriately use a concentrated and powdered product after filtration or the like. I can do it.
本発明の化粧料におけるメラニン産生抑制剤の配合量は、蒸発乾燥分に換算して0.0001〜20.0重量%が好ましく、特に0.01〜10.0重量%の範囲が最適である。 The blending amount of the melanin production inhibitor in the cosmetic of the present invention is preferably 0.0001 to 20.0% by weight, particularly 0.01 to 10.0% by weight in terms of the evaporated and dried content. .
本発明の化粧料は、上記必須成分のほか、水性成分、油性成分、植物抽出物、動物抽出物、粉末、賦形剤、界面活性剤、油剤、アルコール、pH調整剤、防腐剤、酸化防止剤、増粘剤、甘味剤、色素、香料等を必要に応じて混合して適宜配合することにより調製される。本発明の化粧料の剤型は特に限定されず、化粧水、乳液、クリーム、パック、パウダー、スプレー、軟膏、分散液、洗浄料等種々の剤型とすることができる。 In addition to the above essential components, the cosmetics of the present invention are aqueous components, oily components, plant extracts, animal extracts, powders, excipients, surfactants, oils, alcohols, pH adjusters, preservatives, antioxidants. It is prepared by mixing agents and thickeners, sweeteners, pigments, fragrances, and the like as necessary and blending appropriately. The dosage form of the cosmetic of the present invention is not particularly limited, and can be various dosage forms such as lotion, milky lotion, cream, pack, powder, spray, ointment, dispersion, and cleaning agent.
以下、本発明によるセリンプロテアーゼ阻害剤、なかでもトリプシン阻害剤、およびメラニン産生抑制剤による美白効果に関する実施例を示すと共にその素材を用いた化粧料への応用処方例等について述べるが、ここに記載された実施例に限定されないのは言うまでもない。 Examples of serine protease inhibitors according to the present invention, in particular, trypsin inhibitors, and whitening effects by melanin production inhibitors will be described below, and examples of prescriptions applied to cosmetics using the materials will be described. It goes without saying that the present invention is not limited to the embodiment described.
トリプシン阻害効果を測定する植物抽出物としては、ユリ科アマドコロ属植物としてナルコユリの根茎、ネギ属植物としてニラの種子、マメ科クララ属植物としてクララの種子、クズ属植物としてクズの花、ダイズ属植物としてダイズ種子、フジ属植物としてノダフジの花穂、フォエヌム・グラエクム属植物としてコロハの種子、ウリ科カボチャ属植物としてカボチャの種子、ニガウリ属植物としてニガウリの果実、ヘチマ属植物としてヘチマの種子、タデ科ソバ属植物としてソバ種子、セリ科ウイキョウ属植物としてウイキョウの種子、アブラナ科アルバ属植物としてシロガラシの種子を乾燥したのち粉砕し、50%エタノール水溶液で室温で1週間放置し、エキスを抽出した。抽出したエキスは蒸発残分を測定し、2%濃度になるように調製した。さらに、2%濃度に調製した植物エキスに、0023に記載した沈澱試薬を等量加え、タンパク類を除去し、1%濃度の植物抽出エキスとした。 The plant extracts for measuring the trypsin inhibitory effect include the roots of Narcolili as a plant of the genus Amadocora, the seeds of leek as the plant of the genus Leek, the seeds of Clara as the plant of the genus Clariaceae, the flower of the genus Kuzu, Soybean seeds as plants, Nodafuji's ears as genus Fuji, Koroha seeds as Forenum glacum genus plants, Pumpkin seeds as cucurbitaceae genus pumpkins, Nigauri fruit as genus genus plants, Loofah seeds as seedlings, Tade Dry buckwheat seeds as genus buckwheat plants, fennel seeds as celebratory genus plants, and white seeds as cruciferous alba genus plants, pulverize them, leave them in 50% ethanol aqueous solution at room temperature for 1 week, and extract the extract . The extracted extract was prepared by measuring the evaporation residue to a concentration of 2%. Furthermore, an equal amount of the precipitation reagent described in 0023 was added to the plant extract prepared to a concentration of 2% to remove proteins to obtain a plant extract of 1% concentration.
(トリプシン阻害活性の測定)
〔試 薬〕
リン酸緩衝液 :0.1M−NaH2PO4と0.1M−Na2HPO4を5:25で混ぜPH7.4に調製する。
基質溶液 :カゼイン(Hammerstein Cazein)0.6gを0.05M−Na2HPO4 80mlに
加え、沸騰水浴中で加熱溶解させる。冷却後、PHを7.4に調製する。
トリプシン溶液:1:250トリプシン(DIFCO)を10μg/mlになるようにリン酸緩衝液に溶解
する。
沈澱試薬 :トリクロル酢酸、酢酸Na、酢酸溶液を、それぞれ0.11M、0.22M、0.33M
濃度になるように溶液を調製する。
試料溶液 :所定の濃度になるように水またはエタノールを加え調製する。
〔測 定〕
カゼイン基質溶液0.9mlに試料溶液0.1mlを加え混合する。さらに、トリプシン溶液2ml
を加え撹拌し、37℃で10分間放置する。沈澱試薬3ml加えよく撹拌し、室温で15分間放置する。その後3.000rpm、15分間遠心し、上澄み液をとり280nmの吸光度を測定する。
〔阻害率の測定〕
阻害率の算定は式1により求める。
コントロール(C):トリプシン溶液を沈澱試薬の後に添加する。
対照(T):試料の代わりに蒸留水を用いたもの。
試験区(S):各試料を用いて上記の操作を行ったもの。
(Measurement of trypsin inhibitory activity)
(Reagent)
Phosphate buffer solution: 0.1M-NaH 2 PO 4 and 0.1M-Na 2 HPO 4 are mixed at 5:25 to prepare PH7.4.
Substrate solution: 0.6 g of Hammerstein Cazein to 80 ml of 0.05M-Na 2 HPO 4
In addition, it is dissolved by heating in a boiling water bath. After cooling, adjust PH to 7.4.
Trypsin solution: 1: 250 Trypsin (DIFCO) dissolved in phosphate buffer to a concentration of 10 μg / ml
To do.
Precipitation reagent: Trichloroacetic acid, Na acetate, and acetic acid solution, 0.11M, 0.22M, 0.33M, respectively
Prepare the solution to a concentration.
Sample solution: Prepare by adding water or ethanol to a predetermined concentration.
(Measurement)
Add 0.1 ml of sample solution to 0.9 ml of casein substrate solution and mix. In addition, trypsin solution 2ml
Add and stir and leave at 37 ° C for 10 minutes. Add 3 ml of precipitation reagent, stir well and let stand at room temperature for 15 minutes. Thereafter, the mixture is centrifuged at 3.000 rpm for 15 minutes, and the supernatant is taken and the absorbance at 280 nm is measured.
(Measurement of inhibition rate)
The inhibition rate is calculated by Equation 1.
Control (C): Trypsin solution is added after the precipitation reagent.
Control (T): Distilled water was used instead of the sample.
Test section (S): A sample obtained by performing the above operation using each sample.
〔式1〕
[Formula 1]
表-1に各種植物抽出エキスのトリプシン阻害率を示した。なお、陽性対照物質としては、トリプシン阻害薬として生化学分野で汎用されているロイペプチンを使用し、各種植物抽出エキスと比較した。 Table 1 shows the trypsin inhibition rates of various plant extracts. As a positive control substance, leupeptin, which is widely used in the biochemical field as a trypsin inhibitor, was used and compared with various plant extracts.
表-1より、陽性対照物質として試験したロイペプチンは0.1%濃度で65.0%のトリプシン阻害率を示した。なお、本試験に用いた植物抽出エキスは、トリクロル酢酸を含む沈澱試薬でタンパクを沈澱させたエキスを調製し、試験に用いた。これは、従来の植物由来のトリプシン阻害剤は、タンパク類が多く知られていた。しかし、植物抽出エキスを皮膚に塗布する場合は、タンパク類は分子量が大きくほとんど経皮吸収されない。本実験ではこの点を考慮し、タンパク類でない、トリプシン阻害剤の検索を行った。その結果、表-1より各種植物抽出エキスは、いずれも高い阻害活性を示した。なかでも、ダイズ、コロハ、ヘチマ、ソバ抽出エキスは、0.5%濃度でいずれも50%以上の阻害を示し、ダイズ、ヘチマ抽出液は0.1%濃度で陽性対照物質のロイペプチンとほぼ同等の阻害活性を示すことがわかった。 From Table 1, leupeptin tested as a positive control substance showed a trypsin inhibition rate of 65.0% at 0.1% concentration. In addition, the plant extract used for this test prepared the extract which precipitated the protein with the precipitation reagent containing a trichloroacetic acid, and used it for the test. This is because many conventional trypsin inhibitors derived from plants are known to be proteins. However, when a plant extract is applied to the skin, proteins have a large molecular weight and are hardly absorbed through the skin. In this experiment, considering this point, we searched for trypsin inhibitors that are not proteins. As a result, from Table 1, all plant extracts showed high inhibitory activity. Among them, extracts of soybean, fenugreek, loofah, and buckwheat show inhibition of 50% or more at 0.5% concentration, and soybean and loofah extract have almost the same inhibitory activity as leupeptin as a positive control substance at 0.1% concentration. I found out.
次に、本発明の各種成分を配合した化粧料の処方例の例を示すが、本発明はこれに限定されるものでない。 Next, although the example of the formulation example of the cosmetics which mix | blended various components of this invention is shown, this invention is not limited to this.
(1)化粧用クリーム
(重量%)
a)ミツロウ
2.0
b)ステアリルアルコール
5.0
c)ステアリン酸
8.0
d)スクワラン
10.0
e)自己乳化型グリセリルモノステアレート
3.0
f)ポリオキシエチレンセチルエーテル(20E.O.)
1.0
g)ホホバ油 10.0
h)ヘチマ抽出物
0.5
i)アスコルビン酸グルコシド 2.0
j)1,3-ブチレングリコール
5.0
k)水酸化カリウム
0.3
l)防腐剤・酸化防止剤
適量
m)精製水
残部
製法 a)〜f)までを加熱溶解し、80℃に保つ。H)〜m)までを加熱溶解し、80℃に保ち、a)〜f)に加えて乳化し、40℃まで撹拌しながら冷却する。その後、g)を加え、攪拌し均一に溶解する。
(1) Cosmetic cream
(weight%)
a) Beeswax
2.0
b) Stearyl alcohol
5.0
c) Stearic acid
8.0
d) Squalane
10.0
e) Self-emulsifying glyceryl monostearate
3.0
f) Polyoxyethylene cetyl ether (20E.O.)
1.0
g) Jojoba oil 10.0
h) Loofah extract
0.5
i) Ascorbic acid glucoside 2.0
j) 1,3-butylene glycol
5.0
k) Potassium hydroxide
0.3
l) Preservatives and antioxidants
Appropriate amount
m) Purified water
The remaining preparation methods a) to f) are dissolved by heating and kept at 80 ° C. Heat up to H) to m), keep at 80 ° C., add to a) to f), emulsify, and cool to 40 ° C. with stirring. Then g) is added and stirred to dissolve uniformly.
(2)乳液
(重量%)
a)ミツロウ
0.5
b)ワセリン
2.0
c)スクワラン
8.0
d)ソルビタンセスキオレエート
0.8
e)ポリオキシエチレンオレイルエーテル(20E.O.) 1.2
f)クズ抽出物
1.0
g)アルブチン
2.0
h)1,3-ブチレングリコール
7.0
i)カルボキシビニルポリマー
0.2
j)水酸化カリウム
0.1
k)精製水
残部
l)防腐剤・酸化防止剤
適量
m)エタノール
7.0
製法 a)〜e)までを加熱溶解し、80℃に保つ。h)〜l)までを加熱溶解し、80℃に保ち、a)〜e)に加えて乳化し、50℃まで撹拌しながら冷却する。50℃でf)、g)、m)を添加し、40℃まで攪拌、冷却する。
(2) Latex
(weight%)
a) Beeswax
0.5
b) Petrolatum
2.0
c) Squalane
8.0
d) Sorbitan sesquioleate
0.8
e) Polyoxyethylene oleyl ether (20E.O.) 1.2
f) Scrap extract
1.0
g) Arbutin
2.0
h) 1,3-butylene glycol
7.0
i) Carboxyvinyl polymer
0.2
j) Potassium hydroxide
0.1
k) Purified water
The rest
l) Preservatives and antioxidants
Appropriate amount
m) ethanol
7.0
The process up to production methods a) to e) are dissolved by heating and kept at 80 ° C. Heat up to h) to l), keep at 80 ° C., add to a) to e), emulsify, and cool to 50 ° C. with stirring. Add f), g), m) at 50 ° C., stir to 40 ° C. and cool.
(3)化粧水
(重量%)
a)ソバ抽出物
0.1
b)アスコルビン酸リン酸マグネシウム
1.0
c)グリセリン
5.0
d)ポリオキシエチレンソルビタンモノラウレート(20E.O.) 1.0
e)エタノール
6.0
f)香料 適量
g)防腐剤・酸化防止剤
適量
h)精製水
残部
製法 a)とb)を均一に混合する。c)〜h)までを混合し、均一に溶解する。使用時に2剤を混合して使用する。
(3) Lotion
(weight%)
a) Buckwheat extract
0.1
b) Magnesium ascorbate phosphate
1.0
c) Glycerin
5.0
d) Polyoxyethylene sorbitan monolaurate (20E.O.) 1.0
e) ethanol
6.0
f) Perfume appropriate amount
g) Preservatives and antioxidants
Appropriate amount
h) Purified water
The remaining preparation methods a) and b) are mixed uniformly. c) to h) are mixed and dissolved uniformly. Mix two agents when using.
(4)化粧水
(重量%)
a)コロハ抽出物 0.05
b)グルタチオン 0.1
c)グリセリン
5.0
d)ポリオキシエチレンソルビタンモノラウレート(20E.O.)
1.0
e)エタノール
6.0
f)香料 適量
g)防腐剤・酸化防止剤
適量
h)精製水
残部
製法 a)〜b)までを混合する。c)〜h)までを混合し、均一に溶解する。使用時に2剤を混合して使用する。
(4) Lotion
(weight%)
a) Fenugreek extract 0.05
b) Glutathione 0.1
c) Glycerin
5.0
d) Polyoxyethylene sorbitan monolaurate (20E.O.)
1.0
e) ethanol
6.0
f) Perfume appropriate amount
g) Preservatives and antioxidants
Appropriate amount
h) Purified water
Mix the remaining preparation methods a) to b). c) to h) are mixed and dissolved uniformly. Mix two agents when using.
(5)洗顔剤
(重量%)
a)ダイズ抽出物
0.5
b)アスコルビン酸グルコシド
2.0
c)シャクヤク抽出液 0.5
d)タルク
残部
e)セルロース
20.0
f)ミリスチン酸カリウム 30.0
g)ラウリルリン酸ナトリウム
10.0
h)香料
適量
i)防腐剤
適量
製法 a)〜i)までを混合し、よく撹拌、分散させ均一にする。
(5) Face wash
(weight%)
a) Soybean extract
0.5
b) Ascorbic acid glucoside
2.0
c) Peonies extract 0.5
d) Talc
The rest
e) Cellulose
20.0
f) Potassium myristate 30.0
g) Sodium lauryl phosphate
10.0
h) Fragrance
Appropriate amount
i) Preservatives
Appropriate amount of production method a) to i) are mixed and stirred and dispersed well to make uniform.
〔効果確認試験〕
(1)塗布によるヒトでの効果確認試験
被験者として、25〜55歳の女性20名に1日2回(朝、夜)連続2.5ヵ月間、本発明品と比較品のそれぞれを使用させ、塗布部位の状態を試験前後で比較し、改善効果を調べた。本試験には、試験品として0029で示した化粧料を用い、対照品 1 には0029に示した化粧料からヘチマ抽出物を除いた化粧料、対照品 2 には0029に示した化粧料からアスコルビン酸グルコシドを除いた化粧料を作成し、その使用による効果について調べた。そして、本発明の有効成分を配合した化粧料を毎日使用しながら肌のクスミおよび美白効果を塗布開始前及び2ヶ月塗布後におけるアンケートで集計し、効果の確認を行った。その結果を表-2に示す。
[Effect confirmation test]
(1) As a test subject for human effect by application, 20 females aged 25 to 55 years old use the products of the present invention and comparative products twice a day (morning and night) for 2.5 consecutive months. The state of the application site was compared before and after the test to investigate the improvement effect. In this study, cosmetics using shown in 0029 as a test, cosmetics excluding loofah extract from cosmetics shown in 0029 in the control product 1, the cosmetics shown in 0029 in the control product 2 A cosmetic material from which ascorbic acid glucoside was removed was prepared, and the effects of its use were investigated. Then, while using the cosmetics containing the active ingredient of the present invention every day, skin smears and whitening effects were tabulated before and after application for 2 months, and the effects were confirmed. The results are shown in Table-2.
表-2からも明らかなように、従来のメラニン産生抑制剤のみからなる対照品 1 、セリンプロテアーゼ阻害剤のみからなる対照品 2 と比較して、メラニン産生抑制物質およびセリンプロテアーゼ阻害物質からなる試験品は、評点合計が80点となった。これに対して対照品1は53点、対照品2の評点合計は52点であり、本発明品の高い美白効果が認められた。 As is clear from Table 2, the test consisting of a melanin production inhibitor and a serine protease inhibitor compared to a control product 1 consisting only of a conventional melanin production inhibitor and a control product 2 consisting only of a serine protease inhibitor. The product scored a total of 80 points. On the other hand, the control product 1 had 53 points and the control product 2 had a total score of 52 points, and the high whitening effect of the product of the present invention was recognized.
本発明は、皮膚刺激性や皮膚感作性といった安全性上の問題がなく、メラニン産生抑制物質とセリンプロテアーゼ阻害剤を提供することにより、高い美白効果を有する医薬品及び化粧品への応用が広く期待できる。 The present invention has no safety problems such as skin irritation and skin sensitization, and is widely expected to be applied to pharmaceuticals and cosmetics having a high whitening effect by providing a melanin production inhibitor and a serine protease inhibitor. it can.
Claims (1)
L.)、クズ属植物がクズ(Pueraria lobata (Willd.)ohwi)、フジ属がノダフジ(Wistaria Floribunda(Willd.)DC.)、ヤマフジ(W.brachybotrys Siebold et Zucc.)、フォエヌム・グラエクム属がコロハ(Trigonella foenum−graecum L.)、ウリ科カボチャ属がカボチャ(Cucurbita moschata(Duchesne)Poir. var. meloniformis(Carriere)Makino)、セイヨウカボチャ(C.pepo L.)、ニガウリ属がツルレイシ(Momordicacharantia L.)(別名ニガウリ)、タデ科ソバ属がソバ(Fagopyrum esculentum Moench)、(F.dibotrys(D.Don)H.Hara)から選ばれる1種又は2種以上の除タンパクをした抽出物からなるセリンプロテアーゼ阻害剤。 Lilyaceae Amadokora plants are Amagonokoro (Polygonatum odoratum (Mill.) Druce var. Pluriflorum (Miq.) Ohwi), Japanese apricots (P. humile Fisch.), Allium plants are leek (Allium tuberosum ROTLER), Leguminosae Are Clara (Sophora flavescens Aiton), Enju (S. japonica L.), Isofuji (S. tomentosa)
L.), Kudzu plant is Kudzu (Pueraria lobata (Willd.) Ohwi), Fuji genus is Nodafuji (Wistaria Floribunda (Willd.) DC.), Yamafuji (W.brachybotrys Siebold et Zucc.), Forenum Graekum genus Fenugreek (Trigonella foenum-graecum L.), Cucurbita moschata (Duchesne) Poir. Var. Meloniformis (Carriere) Makino, E. paposa (C. pepo L.), Bitter moth (Momordicacharantia L) .) (Also known as bitter gourd), the genus buckwheat is composed of an extract from one or more deproteinized species selected from buckwheat (Fagopyrum esculentum Moench) and (F.dibotrys (D.Don) H.Hara) Serine protease inhibitor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005099907A JP5053519B2 (en) | 2005-03-30 | 2005-03-30 | Plant trypsin inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005099907A JP5053519B2 (en) | 2005-03-30 | 2005-03-30 | Plant trypsin inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006273809A JP2006273809A (en) | 2006-10-12 |
JP5053519B2 true JP5053519B2 (en) | 2012-10-17 |
Family
ID=37208894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005099907A Active JP5053519B2 (en) | 2005-03-30 | 2005-03-30 | Plant trypsin inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5053519B2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4452203B2 (en) * | 2005-03-30 | 2010-04-21 | 株式会社ナリス化粧品 | Whitening cosmetics |
JP5010879B2 (en) * | 2006-09-07 | 2012-08-29 | 常盤薬品工業株式会社 | Liquid composition |
JP5116328B2 (en) * | 2007-03-22 | 2013-01-09 | 株式会社ノエビア | External preparation for skin and food and drink |
KR20100065168A (en) * | 2007-08-27 | 2010-06-15 | 디에스엠 아이피 어셋츠 비.브이. | Tryptase inhibiting mustard extract |
JP5275779B2 (en) * | 2008-03-19 | 2013-08-28 | 株式会社コーセー | Whitening agent and external preparation for skin |
JP2011068576A (en) * | 2009-09-24 | 2011-04-07 | Pola Chemical Industries Inc | External preparation for skin whitening |
JP2011079768A (en) * | 2009-10-06 | 2011-04-21 | National Institute Of Advanced Industrial Science & Technology | Medicament for inhibiting melanogenic in-vivo substance |
US9421236B2 (en) | 2010-12-17 | 2016-08-23 | Johnson & Johnson Consumer Inc. | Compositions comprising Lilium siberia extracts and uses thereof |
US8481093B2 (en) | 2010-12-17 | 2013-07-09 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising Lilium candidum extracts and uses thereof |
CN102579296B (en) * | 2012-03-14 | 2013-10-16 | 上海应用技术学院 | Sun block composition containing momordica charantia extract and application thereof |
JP6595192B2 (en) * | 2014-02-25 | 2019-10-23 | 日本メナード化粧品株式会社 | A skin external preparation or an internal preparation containing an extract of fenugreek cultivated by irradiation with light having a specific wavelength range. |
JP6338107B2 (en) * | 2014-09-30 | 2018-06-06 | 株式会社東洋新薬 | Skin barrier function improving agent, intercellular adhesion structure formation promoter, tight junction formation promoter, and TRPV4 gene expression enhancer |
CN105919851A (en) * | 2016-04-07 | 2016-09-07 | 吴金霞 | Whitening and bathing liquid containing towel gourd |
CN106619167A (en) * | 2016-11-25 | 2017-05-10 | 南京泛成生物化工有限公司 | Composition capable of whitening and brightening, preparation method thereof and application thereof in cosmetics |
CN108181370A (en) * | 2018-01-08 | 2018-06-19 | 太原科技大学 | Preparation, determination of activity and the inhibition constant method for measuring of Fructus Sophorae trypsin inhibitor |
CN112807254A (en) * | 2020-03-23 | 2021-05-18 | 上海铮信生物科技有限公司 | Skin repair composition and application thereof in cosmetics |
CN111388367B (en) * | 2020-03-25 | 2021-09-24 | 江南大学 | Composition for inhibiting melanin at multiple target points, preparation method and application of composition in cosmetics |
CN112021304A (en) * | 2020-09-17 | 2020-12-04 | 山东省齐鲁干细胞工程有限公司 | Cryopreservation method and recovery method of umbilical cord mesenchymal stem cells |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61194008A (en) * | 1985-02-25 | 1986-08-28 | Shiseido Co Ltd | Cosmetic |
JP2711782B2 (en) * | 1991-12-25 | 1998-02-10 | 花王株式会社 | Whitening cosmetics |
JP2000109417A (en) * | 1998-10-05 | 2000-04-18 | Pola Chem Ind Inc | Cosmetic for improving somber color |
JP4869482B2 (en) * | 2000-08-18 | 2012-02-08 | 株式会社ノエビア | Whitening cosmetics |
JP2002087946A (en) * | 2000-09-11 | 2002-03-27 | Pola Chem Ind Inc | Composition for bleaching |
JP2003095858A (en) * | 2001-09-27 | 2003-04-03 | Nonogawa Shoji Kk | Skin care preparation |
JP4091824B2 (en) * | 2002-02-05 | 2008-05-28 | 株式会社コーセー | Skin preparation |
JP4452203B2 (en) * | 2005-03-30 | 2010-04-21 | 株式会社ナリス化粧品 | Whitening cosmetics |
-
2005
- 2005-03-30 JP JP2005099907A patent/JP5053519B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2006273809A (en) | 2006-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5053519B2 (en) | Plant trypsin inhibitor | |
JP4452203B2 (en) | Whitening cosmetics | |
CN105555366A (en) | Extracts fo halimione portulacoides and their application | |
JP2008239545A (en) | Elastase deactivator | |
JPH0930946A (en) | Beautifying and whitening dermal preparation for external use | |
JPH10330219A (en) | Melanogenesis inhibitor and skin whitening agent | |
JP2004231558A (en) | External preparation for skin for bleaching | |
JPH0812566A (en) | Inhibitor of tyrosinase activity | |
JP5154835B2 (en) | Whitening cosmetics | |
JP2009209063A (en) | Skin preparation for external use, or skin cosmetic | |
JP2001288098A (en) | Melanogenesis promoter and gray hair ameliorant | |
JPH07258063A (en) | External preparation for skin | |
JP2008247841A (en) | Skin-lightening agent and melanin generation inhibitor | |
JPH0930949A (en) | Beautifying and whitening dermal preparation for external use | |
JPH09157151A (en) | Melanin generation inhibitor and whitening agent | |
JP3647296B2 (en) | Inhibition of tyrosinase activity and compositions containing the same | |
JPH0930948A (en) | Beautifying and whitening dermal preparation for external use | |
JP2002060337A (en) | Skin care preparation | |
JPH05271045A (en) | Cosmetic | |
JP4959103B2 (en) | Whitening agent and external preparation for skin | |
JP2009073769A (en) | Melanin formation inhibitor and cosmetic for bleaching | |
JPH11246344A (en) | Preparation for external use for skin bleaching | |
JP2000159657A (en) | Cosmetic | |
JP2002255734A (en) | Elastase activity inhibitor and anti-aging agent comprising the same | |
JPH0812557A (en) | Skin external preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080229 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100805 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110517 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110719 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120702 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120724 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120726 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5053519 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150803 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |